DNMT2 (TRDMT1) Antibody (Center L232) Blocking peptide

DNMT2 (TRDMT1) Antibody (Center L232) Blocking peptide

€363.00
In stock
SKU
AC-BP1021c
Catalog Number: AC-BP1021c
Size: 500 µg
Datasheet
Request Information
Background:
CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. TRDMT1 shows similarity to DNA methyltransferases, but this protein does not display methyltransferase activity. The protein strongly binds DNA, suggesting that it may mark specific sequences in the genome.

Other Names:
tRNA (cytosine(38)-C(5))-methyltransferase, DNA (cytosine-5)-methyltransferase-like protein 2, Dnmt2, DNA methyltransferase homolog HsaIIP, DNA MTase homolog HsaIIP, MHsaIIP, PuMet, TRDMT1, DNMT2

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1021c was selected from the DNMT2 region of human TRDMT1 (DNMT2). A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: TRDMT1

Gene ID: 1787
Primary Accession: O14717
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:DNMT2 (TRDMT1) Antibody (Center L232) Blocking peptide